Cytosar 100 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Cytosar 100 mg Injection

Cytosar 100 mg Injection

Cytosar 100 mg Injection contains cytarabine, an antineoplastic medicine used in the treatment of certain blood cancers. It interferes with DNA synthesis and helps inhibit the growth of rapidly dividing cancer cells. The medicine is administered by a healthcare professional according to the prescribed chemotherapy protocol.

BUY NOW

Category

Cytosar 100 mg Injection contains 100 mg of cytarabine per vial and is supplied as a powder that requires reconstitution before use. Cytarabine is primarily used in chemotherapy regimens for acute myeloid leukemia and other selected leukemias. When reconstituted with 5 mL of suitable diluent, the 100 mg vial produces a nominal concentration of 20 mg/mL. The route, dosage, dilution, and treatment schedule depend on the specific clinical protocol and must be determined by the treating specialist.

Technical Specification

Specification Details
Active Ingredient Cytarabine 100 mg
Dosage Form Powder for Solution for Injection
Nominal Concentration After Reconstitution 20 mg/mL
Diluent Volume 5 mL
Therapeutic Class Antimetabolite
Main Indication Acute Myeloid Leukemia

Product Also Known As

Cytosar 100 mg Injection, Cytosar 100 mg Vial, Cytarabine 100 mg Injection, Cytarabine 100 mg Vial, Cytarabine Oncology Injection, Ara-C 100 mg Injection